FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009667440> ?p ?o ?g. }

• W2009667440 endingPage "1529" @default.
• W2009667440 startingPage "1519" @default.
• W2009667440 abstract "A new route to N-1-substituted pyrazolo- and pyrroloquinazolines has been developed from the known quinazolones 19 and 23, via conversion to the corresponding thiones, S-methylation to the thioethers, N-1-alkylation, and coupling with 3-bromoaniline. C-3-Substituted pyrroloquinazolines were prepared by Mannich base chemistry. A series of compounds bearing solubilizing side chains at these positions has been prepared and evaluated for inhibition of the tyrosine kinase activity of the isolated epidermal growth factor receptor (EGFR) and of its autophosphorylation in EGF-stimulated A431 cells. Several analogues, particularly C-3-substituted pyrroloquinazolines, retained high potency in both assays. A model for the binding of the general class of 4-anilinoquinazolines to the EGFR was constructed from structural information (particularly for the catalytic subunit of the cAMP-dependent protein kinase) and structure-activity relationships (SAR) in the series. In this model, the pyrrole ring in pyrroloquinazolines (and the 6- and 7-positions of quinazoline and related pyridopyrimidine inhibitors) occupies the entrance of the ATP binding pocket of the enzyme, with the pyrrole nitrogen located at the bottom of the cleft and the pyrrole C-3 position pointing toward a pocket corresponding to the ribose binding site of ATP. This allows considerable bulk tolerance for C-3 substituents and lesser but still significant bulk tolerance for N-1 substituents. The observed high selectivity of these compounds for binding to EGFR over other similar tyrosine kinases is attributed to the 4-anilino ring binding in an adjacent hydrophobic pocket which has an amino acid composition unique to the EGFR. The SAR seen for inhibition of the isolated enzyme by the pyrazolo- and pyrroloquinazolines discussed here is fully consistent with this binding model. For the N-1-substituted compounds, inhibition of autophosphorylation in A431 cells correlates well with inhibition of the isolated enzyme, as seen previously for related pyridopyrimidines. However, the C-3-substituted pyrroloquinazolines show unexpectedly high potencies in the autophosphorylation assay, making them of particular interest." @default.
• W2009667440 created "2016-06-24" @default.
• W2009667440 creator A5023901201 @default.
• W2009667440 creator A5033059231 @default.
• W2009667440 creator A5051479303 @default.
• W2009667440 creator A5060190926 @default.
• W2009667440 creator A5082013627 @default.
• W2009667440 creator A5091278547 @default.
• W2009667440 date "1997-05-01" @default.
• W2009667440 modified "2023-10-12" @default.
• W2009667440 title "Tyrosine Kinase Inhibitors. 11. Soluble Analogues of Pyrrolo- and Pyrazoloquinazolines as Epidermal Growth Factor Receptor Inhibitors: Synthesis, Biological Evaluation, and Modeling of the Mode of Binding" @default.
• W2009667440 cites W1524096981 @default.
• W2009667440 cites W1975501812 @default.
• W2009667440 cites W1995680891 @default.
• W2009667440 cites W2006930438 @default.
• W2009667440 cites W2007829086 @default.
• W2009667440 cites W2016255909 @default.
• W2009667440 cites W2017091728 @default.
• W2009667440 cites W2052221882 @default.
• W2009667440 cites W2066498455 @default.
• W2009667440 cites W2072970918 @default.
• W2009667440 cites W2088483249 @default.
• W2009667440 cites W2160053097 @default.
• W2009667440 cites W2160230313 @default.
• W2009667440 cites W4236543050 @default.
• W2009667440 cites W975765317 @default.
• W2009667440 doi "https://doi.org/10.1021/jm960789h" @default.
• W2009667440 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9154973" @default.
• W2009667440 hasPublicationYear "1997" @default.
• W2009667440 type Work @default.
• W2009667440 sameAs 2009667440 @default.
• W2009667440 citedByCount "99" @default.
• W2009667440 countsByYear W20096674402012 @default.
• W2009667440 countsByYear W20096674402013 @default.
• W2009667440 countsByYear W20096674402014 @default.
• W2009667440 countsByYear W20096674402015 @default.
• W2009667440 countsByYear W20096674402016 @default.
• W2009667440 countsByYear W20096674402017 @default.
• W2009667440 countsByYear W20096674402018 @default.
• W2009667440 countsByYear W20096674402019 @default.
• W2009667440 countsByYear W20096674402020 @default.
• W2009667440 countsByYear W20096674402021 @default.
• W2009667440 countsByYear W20096674402022 @default.
• W2009667440 crossrefType "journal-article" @default.
• W2009667440 hasAuthorship W2009667440A5023901201 @default.
• W2009667440 hasAuthorship W2009667440A5033059231 @default.
• W2009667440 hasAuthorship W2009667440A5051479303 @default.
• W2009667440 hasAuthorship W2009667440A5060190926 @default.
• W2009667440 hasAuthorship W2009667440A5082013627 @default.
• W2009667440 hasAuthorship W2009667440A5091278547 @default.
• W2009667440 hasConcept C107824862 @default.
• W2009667440 hasConcept C150109051 @default.
• W2009667440 hasConcept C161790260 @default.
• W2009667440 hasConcept C164361826 @default.
• W2009667440 hasConcept C170493617 @default.
• W2009667440 hasConcept C178790620 @default.
• W2009667440 hasConcept C184235292 @default.
• W2009667440 hasConcept C185592680 @default.
• W2009667440 hasConcept C2776165026 @default.
• W2009667440 hasConcept C2776362946 @default.
• W2009667440 hasConcept C2778866207 @default.
• W2009667440 hasConcept C2779400197 @default.
• W2009667440 hasConcept C42362537 @default.
• W2009667440 hasConcept C55493867 @default.
• W2009667440 hasConcept C71240020 @default.
• W2009667440 hasConcept C97029542 @default.
• W2009667440 hasConceptScore W2009667440C107824862 @default.
• W2009667440 hasConceptScore W2009667440C150109051 @default.
• W2009667440 hasConceptScore W2009667440C161790260 @default.
• W2009667440 hasConceptScore W2009667440C164361826 @default.
• W2009667440 hasConceptScore W2009667440C170493617 @default.
• W2009667440 hasConceptScore W2009667440C178790620 @default.
• W2009667440 hasConceptScore W2009667440C184235292 @default.
• W2009667440 hasConceptScore W2009667440C185592680 @default.
• W2009667440 hasConceptScore W2009667440C2776165026 @default.
• W2009667440 hasConceptScore W2009667440C2776362946 @default.
• W2009667440 hasConceptScore W2009667440C2778866207 @default.
• W2009667440 hasConceptScore W2009667440C2779400197 @default.
• W2009667440 hasConceptScore W2009667440C42362537 @default.
• W2009667440 hasConceptScore W2009667440C55493867 @default.
• W2009667440 hasConceptScore W2009667440C71240020 @default.
• W2009667440 hasConceptScore W2009667440C97029542 @default.
• W2009667440 hasIssue "10" @default.
• W2009667440 hasLocation W20096674401 @default.
• W2009667440 hasLocation W20096674402 @default.
• W2009667440 hasOpenAccess W2009667440 @default.
• W2009667440 hasPrimaryLocation W20096674401 @default.
• W2009667440 hasRelatedWork W1445566342 @default.
• W2009667440 hasRelatedWork W1518877053 @default.
• W2009667440 hasRelatedWork W1523093647 @default.
• W2009667440 hasRelatedWork W2012260867 @default.
• W2009667440 hasRelatedWork W2027770667 @default.
• W2009667440 hasRelatedWork W2082656140 @default.
• W2009667440 hasRelatedWork W2167112906 @default.
• W2009667440 hasRelatedWork W2168494337 @default.
• W2009667440 hasRelatedWork W2638455956 @default.
• W2009667440 hasRelatedWork W3012189330 @default.
• W2009667440 hasVolume "40" @default.

• next